Overview

Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage

Status:
RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
To provide a treatment of both actinic keratoses and photodamage within one treatment.
Phase:
PHASE1
Details
Lead Sponsor:
Sherrif Ibrahim
Collaborators:
Biofrontera Bioscience GmbH
Sciton
Treatments:
Aminolevulinic Acid